Differentiated thyroid cancer is divided into papillary and follicular thyroid cancer. These cancer types are called as differentiated cancer since papillary and follicular thyroid cancer differ in their biological behavior and may require distinct therapeutic approach. Differentiated thyroid cancer are most common type of thyroid cancer and most curable among other cancers.
This report aims to provide a comprehensive presentation of the global market for Differentiated Thyroid Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Differentiated Thyroid Cancer Therapeutics. This report contains market size and forecasts of Differentiated Thyroid Cancer Therapeutics in global, including the following market information:
Global Differentiated Thyroid Cancer Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Differentiated Thyroid Cancer Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Radioiodine Ablation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Differentiated Thyroid Cancer Therapeutics include Mylan pharmaceuticals, Takeda, Alara Pharmaceutical, Abbott laboratories, Bristol Myers, Teva and Jerome Stevens, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Differentiated Thyroid Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Differentiated Thyroid Cancer Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Differentiated Thyroid Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
Radioiodine Ablation
Thyroid Stimulating Hormone (THS) Suppression
Chemotherapy
Targeted Multikinase Therapy
Others
Global Differentiated Thyroid Cancer Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Differentiated Thyroid Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Oncology Canters
Hospital Pharmacies
Retail Pharmacies
Global Differentiated Thyroid Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Differentiated Thyroid Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Differentiated Thyroid Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Differentiated Thyroid Cancer Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan pharmaceuticals
Takeda
Alara Pharmaceutical
Abbott laboratories
Bristol Myers
Teva
Jerome Stevens
Outline of Major Chapters:
Chapter 1: Introduces the definition of Differentiated Thyroid Cancer Therapeutics, market overview.
Chapter 2: Global Differentiated Thyroid Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Differentiated Thyroid Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Differentiated Thyroid Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Differentiated Thyroid Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Differentiated Thyroid Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Differentiated Thyroid Cancer Therapeutics Overall Market Size
2.1 Global Differentiated Thyroid Cancer Therapeutics Market Size: 2022 VS 2029
2.2 Global Differentiated Thyroid Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Differentiated Thyroid Cancer Therapeutics Players in Global Market
3.2 Top Global Differentiated Thyroid Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Differentiated Thyroid Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Differentiated Thyroid Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Differentiated Thyroid Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Differentiated Thyroid Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Differentiated Thyroid Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Differentiated Thyroid Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Differentiated Thyroid Cancer Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Radioiodine Ablation
4.1.3 Thyroid Stimulating Hormone (THS) Suppression
4.1.4 Chemotherapy
4.1.5 Targeted Multikinase Therapy
4.1.6 Others
4.2 By Type - Global Differentiated Thyroid Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Differentiated Thyroid Cancer Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Differentiated Thyroid Cancer Therapeutics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Oncology Canters
5.1.4 Hospital Pharmacies
5.1.5 Retail Pharmacies
5.2 By Application - Global Differentiated Thyroid Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Differentiated Thyroid Cancer Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Differentiated Thyroid Cancer Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Differentiated Thyroid Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Differentiated Thyroid Cancer Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2029
6.3.2 US Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.3.3 Canada Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.3.4 Mexico Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2029
6.4.2 Germany Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.4.3 France Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.4.4 U.K. Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.4.5 Italy Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.4.6 Russia Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.4.8 Benelux Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2029
6.5.2 China Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.5.3 Japan Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.5.4 South Korea Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.5.6 India Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2029
6.6.2 Brazil Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.6.3 Argentina Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2029
6.7.2 Turkey Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.7.3 Israel Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
6.7.5 UAE Differentiated Thyroid Cancer Therapeutics Market Size, 2018-2029
7 Differentiated Thyroid Cancer Therapeutics Companies Profiles
7.1 Mylan pharmaceuticals
7.1.1 Mylan pharmaceuticals Company Summary
7.1.2 Mylan pharmaceuticals Business Overview
7.1.3 Mylan pharmaceuticals Differentiated Thyroid Cancer Therapeutics Major Product Offerings
7.1.4 Mylan pharmaceuticals Differentiated Thyroid Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Mylan pharmaceuticals Key News & Latest Developments
7.2 Takeda
7.2.1 Takeda Company Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda Differentiated Thyroid Cancer Therapeutics Major Product Offerings
7.2.4 Takeda Differentiated Thyroid Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Takeda Key News & Latest Developments
7.3 Alara Pharmaceutical
7.3.1 Alara Pharmaceutical Company Summary
7.3.2 Alara Pharmaceutical Business Overview
7.3.3 Alara Pharmaceutical Differentiated Thyroid Cancer Therapeutics Major Product Offerings
7.3.4 Alara Pharmaceutical Differentiated Thyroid Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Alara Pharmaceutical Key News & Latest Developments
7.4 Abbott laboratories
7.4.1 Abbott laboratories Company Summary
7.4.2 Abbott laboratories Business Overview
7.4.3 Abbott laboratories Differentiated Thyroid Cancer Therapeutics Major Product Offerings
7.4.4 Abbott laboratories Differentiated Thyroid Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Abbott laboratories Key News & Latest Developments
7.5 Bristol Myers
7.5.1 Bristol Myers Company Summary
7.5.2 Bristol Myers Business Overview
7.5.3 Bristol Myers Differentiated Thyroid Cancer Therapeutics Major Product Offerings
7.5.4 Bristol Myers Differentiated Thyroid Cancer Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Bristol Myers Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Differentiated Thyroid Cancer Therapeutics Major Product Offerings
7.6.4 Teva Differentiated Thyroid Cancer Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Teva Key News & Latest Developments
7.7 Jerome Stevens
7.7.1 Jerome Stevens Company Summary
7.7.2 Jerome Stevens Business Overview
7.7.3 Jerome Stevens Differentiated Thyroid Cancer Therapeutics Major Product Offerings
7.7.4 Jerome Stevens Differentiated Thyroid Cancer Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Jerome Stevens Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Differentiated Thyroid Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Differentiated Thyroid Cancer Therapeutics Market Drivers in Global Market
Table 3. Differentiated Thyroid Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Differentiated Thyroid Cancer Therapeutics in Global Market
Table 5. Top Differentiated Thyroid Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Differentiated Thyroid Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Differentiated Thyroid Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Differentiated Thyroid Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Differentiated Thyroid Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Differentiated Thyroid Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Differentiated Thyroid Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Differentiated Thyroid Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Differentiated Thyroid Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Differentiated Thyroid Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Mylan pharmaceuticals Company Summary
Table 31. Mylan pharmaceuticals Differentiated Thyroid Cancer Therapeutics Product Offerings
Table 32. Mylan pharmaceuticals Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Mylan pharmaceuticals Key News & Latest Developments
Table 34. Takeda Company Summary
Table 35. Takeda Differentiated Thyroid Cancer Therapeutics Product Offerings
Table 36. Takeda Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Takeda Key News & Latest Developments
Table 38. Alara Pharmaceutical Company Summary
Table 39. Alara Pharmaceutical Differentiated Thyroid Cancer Therapeutics Product Offerings
Table 40. Alara Pharmaceutical Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Alara Pharmaceutical Key News & Latest Developments
Table 42. Abbott laboratories Company Summary
Table 43. Abbott laboratories Differentiated Thyroid Cancer Therapeutics Product Offerings
Table 44. Abbott laboratories Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott laboratories Key News & Latest Developments
Table 46. Bristol Myers Company Summary
Table 47. Bristol Myers Differentiated Thyroid Cancer Therapeutics Product Offerings
Table 48. Bristol Myers Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Bristol Myers Key News & Latest Developments
Table 50. Teva Company Summary
Table 51. Teva Differentiated Thyroid Cancer Therapeutics Product Offerings
Table 52. Teva Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Key News & Latest Developments
Table 54. Jerome Stevens Company Summary
Table 55. Jerome Stevens Differentiated Thyroid Cancer Therapeutics Product Offerings
Table 56. Jerome Stevens Differentiated Thyroid Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Jerome Stevens Key News & Latest Developments
List of Figures
Figure 1. Differentiated Thyroid Cancer Therapeutics Segment by Type in 2022
Figure 2. Differentiated Thyroid Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Differentiated Thyroid Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Differentiated Thyroid Cancer Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Differentiated Thyroid Cancer Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Differentiated Thyroid Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Differentiated Thyroid Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Differentiated Thyroid Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Mylan pharmaceuticals Differentiated Thyroid Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Takeda Differentiated Thyroid Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Alara Pharmaceutical Differentiated Thyroid Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott laboratories Differentiated Thyroid Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol Myers Differentiated Thyroid Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Differentiated Thyroid Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Jerome Stevens Differentiated Thyroid Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
